WHO DG praises Ayushman Bharat scheme on first 100 days of its launch

Published On 2019-01-06 03:35 GMT   |   Update On 2019-01-06 03:35 GMT

Jaitley said in the first 100 days, 6.85 lakh patients have been provided hospital treatment and 5.1 lakh claims have availed of the scheme, for which payment has been released.


New Delhi: The World Health Organization (WHO) Director-General has praised Prime Minister Narendra Modi and Health Minister J P Nadda for their visionary leadership which helped around seven lakh people avail benefits of the healthcare scheme Ayushman Bharat in the first 100 days of its launch.


"In its first 100 days, #India's ambitious #Ayushman Bharat scheme has provided free care for almost 700,000 people. I applaud Prime Minister @narendramodi and Health Minister @JPNadda for their visionary leadership for #HealthForAll (sic), " Director General Tedros Adhanom Ghebreyesus tweeted. ?


He had earlier also praised the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana, which aims to provide insurance cover of Rs five lakh per annum to 50 crore poor people by calling it a "great commitment".








On January 1, Finance Minister Arun Jaitley had termed the government's flagship scheme Ayushman Bharat a 'game changer' in healthcare and said on an average 5,000 claims are being settled every day since its rollout on September 23, 2018.


The total number of hospitals covered by this scheme is 16,000 and increasing steadily. More than 50 per cent of the implementing hospitals are in the private sector.


Jaitley said in the first 100 days, 6.85 lakh patients have been provided hospital treatment and 5.1 lakh claims have availed of the scheme, for which payment has been released.


Prime Minister Narendra Modi in September launched the Ayushman Bharat scheme.


All states and union territories, barring Delhi, Telangana and Odisha, have signed agreements with the health ministry for implementing the scheme.


Read Also: Parliamentary Panel Slams Modicare, says Ayushman Bharat Just a modification of RSBY


Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News